Fubotv earnings beat by $0.10, revenue topped estimates
J.H. Whitney Equity Partners VII, LLC, a significant shareholder in Aveanna Healthcare Holdings , Inc. (NASDAQ:AVAH), has reported a sale of shares totaling $2,518. The transactions, disclosed in a recent SEC filing, occurred over two days, March 24 and March 25, 2025. The shares were sold at prices ranging from $5.63 to $5.64. The sale comes amid AVAH’s impressive market performance, with the stock delivering a 129.91% return over the past year and trading near $5.38, according to InvestingPro data.
The sales involved multiple transactions by entities associated with J.H. Whitney, including J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, and PSA Iliad Holdings LLC. Following these transactions, the reported holdings of these entities in Aveanna Healthcare have been adjusted accordingly. With a market capitalization of $1.05 billion and significant price volatility, investors can access comprehensive analysis and 7 additional key insights through InvestingPro’s detailed research reports.
In other recent news, Aveanna Healthcare Holdings Inc. reported strong financial results for the fourth quarter of 2024, with earnings per share reaching $0.05, surpassing the expected loss of $0.003. The company also exceeded revenue expectations, reporting $519.9 million against a forecast of $499.07 million. These results reflect Aveanna’s effective operational strategies and growth across all divisions, particularly in Private Duty Services, which saw a 10.1% increase. Additionally, Moody’s has affirmed Aveanna’s Caa1 rating and revised its outlook to positive, citing improvements in business performance and leverage reduction. The company’s liquidity remains adequate, supported by $84 million in cash and a revolving credit facility with approximately $138 million available. UBS, however, maintains a Sell rating on Aveanna’s shares, despite raising the price target to $4.50 from $3.20. This reflects ongoing concerns despite recent management changes and operational improvements. These developments indicate Aveanna’s strategic focus on expanding its payer agreements and enhancing service offerings, positioning the company for continued growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.